“Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s119. https://doi.org/10.25251/skin.4.supp.119.